Johnson & Johnson (J&J), the worldÔÇÖs largest health products company, has announced it will acquire medical technology company Acclarent Inc. for $785 million. The deal is expected to significantly boost J&JÔÇÖs presence in the ear, nose and throat treatment business. The venture capital arm of New Brunswick, New Jersey-based J&J began investing in Acclarent a year ago.